ICU Medical Commits to Acquire Smith for ~$2.35B

Shots: Smiths to receive 2.5M at closing in cash and stock which is currently valued at ~$500M, $1.85B in cash along with liabilities & is eligible for up to $100M in milestones. The transaction is expected to close in H1’22 The acquisition combines Smiths’ business includes syringes, ambulatory infusion devices, vascular access & vital care …

ICU Medical Commits to Acquire Smith for ~$2.35B Read More »